Article
[Clozapine-induced agranulocytosis: genetic risk factors and an immunologic explanatory model].
Tijdschrift voor psychiatrie - 1 Jan 2006
Güzelcan Y, Scholte W F
Abstract excerpt
BACKGROUND: Clozapine, an atypical antipsychotic used in the treatment of refractory schizophrenia, causes agranulocytosis in 0.8% of patients. The risk factors for clozapine-induced agranulocytosis (CIA) and the underlying mechanisms are unclear. AIM: To ascertain the genetic and immunological r...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
